Qin YT - Search Results

1

Engineering metal-based hydrogel-mediated tertiary lymphoid structure formation via activation of the STING pathway for enhanced immunotherapy.

Jin XK, Liang JL, Zhang SM, Ji P, Huang QX, Qin YT, Deng XC, Liu CJ, Zhang XZ. Jin XK, et al. Among authors: qin yt. Mater Horiz. 2023 Oct 2;10(10):4365-4379. doi: 10.1039/d3mh00748k. Mater Horiz. 2023. PMID: 37455643

2

Progress of engineered bacteria for tumor therapy.

Fan JX, Niu MT, Qin YT, Sun YX, Zhang XZ. Fan JX, et al. Among authors: qin yt. Adv Drug Deliv Rev. 2022 Jun;185:114296. doi: 10.1016/j.addr.2022.114296. Epub 2022 Apr 16. Adv Drug Deliv Rev. 2022. PMID: 35439571 Review.

3

Living symbiotic bacteria-involved skin dressing to combat indigenous pathogens for microbiome-based biotherapy toward atopic dermatitis.

Liu X, Qin Y, Dong L, Han Z, Liu T, Tang Y, Yu Y, Ye J, Tao J, Zeng X, Feng J, Zhang XZ. Liu X, et al. Bioact Mater. 2022 Sep 12;21:253-266. doi: 10.1016/j.bioactmat.2022.08.019. eCollection 2023 Mar. Bioact Mater. 2022. PMID: 36157249 Free PMC article.

4

Bacteria-Based Backpacks to Enhance Adoptive Macrophage Transfer against Solid Tumors.

An JX, Han ZY, Qin YT, Li CX, He JL, Zhang XZ. An JX, et al. Among authors: qin yt. Adv Mater. 2024 Feb;36(6):e2305384. doi: 10.1002/adma.202305384. Epub 2023 Dec 5. Adv Mater. 2024. PMID: 37672674

5

A PD-L1-targeting Regulator for Metabolic Reprogramming to Enhance Glutamine Inhibition-Mediated Synergistic Antitumor Metabolic and Immune Therapy.

Jin XK, Zhang SM, Liang JL, Zhang SK, Qin YT, Huang QX, Liu CJ, Zhang XZ. Jin XK, et al. Among authors: qin yt. Adv Mater. 2024 Feb;36(6):e2309094. doi: 10.1002/adma.202309094. Epub 2023 Dec 6. Adv Mater. 2024. PMID: 38014890

6

Dendritic Cell-Based In Situ Nanovaccine for Reprogramming Lipid Metabolism to Boost Tumor Immunotherapy.

Qin YT, Liu XH, An JX, Liang JL, Li CX, Jin XK, Ji P, Zhang XZ. Qin YT, et al. ACS Nano. 2023 Dec 26;17(24):24947-24960. doi: 10.1021/acsnano.3c06784. Epub 2023 Dec 6. ACS Nano. 2023. PMID: 38055727

7

Oral Saccharomyces cerevisiae-Guided Enzyme Prodrug Therapy Combined with Immunotherapy for the Treatment of Orthotopic Colorectal Cancer.

Qin YT, Liu X, An JX, Chen Z, Niu MT, Yan X, Li QR, Rao ZY, Zhang XZ. Qin YT, et al. ACS Nano. 2024 Aug 27;18(34):23497-23507. doi: 10.1021/acsnano.4c07115. Epub 2024 Aug 15. ACS Nano. 2024. PMID: 39146387

8

Lactate/Cysteine Dual-Consuming Probiotic-Nanomedicine Biohybrid System for Enhanced Cancer Chemo-Immunotherapy.

Xie TQ, Yan X, Qin YT, Zhang C, Jin XK, Li QR, Rao ZY, Zhou H, Chen WH, Zhang XZ. Xie TQ, et al. Among authors: qin yt. Nano Lett. 2024 Dec 18;24(50):16132-16142. doi: 10.1021/acs.nanolett.4c04938. Epub 2024 Dec 6. Nano Lett. 2024. PMID: 39641324

9

Cationic Magnetic Nanoparticles Activate Natural Killer Cells for the Treatment of Glioblastoma.

Rao ZY, Kuang J, Pan T, Qin YT, Huang QX, Sun YL, Zhao K, Jin XK, Yang CH, Zhang SM, Yan Y, Zhang XZ. Rao ZY, et al. Among authors: qin yt. ACS Nano. 2024 Dec 23. doi: 10.1021/acsnano.4c11250. Online ahead of print. ACS Nano. 2024. PMID: 39711185

10

Establishment of a visualized mouse orthotopic xenograft model of nasopharyngeal carcinoma.

Chen W, Chen WM, Chen SX, Jiang L, Shu GG, Yin YX, Quan ZP, Zhou ZY, Shen MJ, Qin YT, Yang CL, Su XJ, Kang M. Chen W, et al. Among authors: qin yt. Cancer Biol Ther. 2024 Dec 31;25(1):2382531. doi: 10.1080/15384047.2024.2382531. Epub 2024 Aug 29. Cancer Biol Ther. 2024. PMID: 39206791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters